A carregar...

Immunomodulatory effect of vancomycin on Treg in pediatric inflammatory bowel disease and primary sclerosing cholangitis

Vancomycin has been shown to affect tumor necrosis factor-alpha (TNF-α) pathways as an immunomodulator; this is thought to be separate from its function as an antibiotic [1]. Previous studies have shown that oral vancomycin (OV) is an effective treatment for concomitant primary sclerosing cholangiti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Abarbanel, David N., Seki, Scott M., Davies, Yinka, Marlen, Natalie, Benavides, Joseph A., Cox, Kathleen, Nadeau, Kari C., Cox, Kenneth L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3565076/
https://ncbi.nlm.nih.gov/pubmed/23054338
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10875-012-9801-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!